Integra LifeSciences Holdings

NasdaqGS:IART Stock Report

Mkt Cap: US$3.6b

Integra LifeSciences Holdings Financial Health

How is Integra LifeSciences Holdings's financial position?

Financial Health Score

3/6

Financial Health Score 3/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: IART's short term assets ($1.1B) exceed its short term liabilities ($295.6M).

Long Term Liabilities: IART's short term assets ($1.1B) do not cover its long term liabilities ($1.8B).


Debt to Equity History and Analysis

Debt Level: IART's net debt to equity ratio (66.2%) is considered high.

Reducing Debt: IART's debt to equity ratio has reduced from 98.8% to 93.4% over the past 5 years.

Debt Coverage: IART's debt is not well covered by operating cash flow (17%).

Interest Coverage: IART's interest payments on its debt are well covered by EBIT (6.8x coverage).


Balance Sheet


Discover healthy companies